Immunogenicity Safety Study of Wockhardt's Recombinant Insulin Analogue in Type 1 Diabetic Patients
Phase 3
Withdrawn
- Conditions
- Type I Diabetes
- Interventions
- Biological: Lantus®Biological: Wockhardt's Insulin Analogue (Recomb)
- First Posted Date
- 2011-05-12
- Last Posted Date
- 2019-10-08
- Lead Sponsor
- Wockhardt
- Registration Number
- NCT01352663
Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics
Phase 3
Terminated
- Conditions
- Type I Diabetes
- Interventions
- Biological: Novolin® (N or 70/30 with R)Biological: Wosulin (N or 70/30 with R)
- First Posted Date
- 2011-03-04
- Last Posted Date
- 2023-06-23
- Lead Sponsor
- Wockhardt
- Target Recruit Count
- 134
- Registration Number
- NCT01308437
- Locations
- 🇺🇸
Sergio Rovner, MD, El Paso, Texas, United States
🇺🇸Baptist Diabetes Associates, PA, Miami, Florida, United States
🇺🇸University Diabetes & Endocrine Association, Chattanooga, Tennessee, United States
Comparative Glucose Clamp Study of Wockhardt's Human Isophane Insulin With Novolin N,in Healthy Subjects
Phase 1
Completed
- Conditions
- Diabetes
- Interventions
- Biological: Novolin NBiological: Wosulin N
- First Posted Date
- 2008-10-15
- Last Posted Date
- 2012-12-27
- Lead Sponsor
- Wockhardt
- Target Recruit Count
- 56
- Registration Number
- NCT00772265
- Locations
- 🇺🇸
Profil Institute for clinical Research, Chula Vista, California, United States
Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Type 1 Diabetics
Phase 1
Completed
- Conditions
- Diabetes
- Interventions
- Biological: ActrapidBiological: Wosulin R
- First Posted Date
- 2008-09-15
- Last Posted Date
- 2012-12-27
- Lead Sponsor
- Wockhardt
- Target Recruit Count
- 28
- Registration Number
- NCT00752180
- Locations
- 🇺🇸
Profil Institute for Clinical Research, Chula Vista, California, United States
Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Healthy Subjects.
Phase 1
Completed
- Conditions
- Diabetes
- Interventions
- Biological: Wosulin RBiological: Actrapid
- First Posted Date
- 2008-07-21
- Last Posted Date
- 2012-12-27
- Lead Sponsor
- Wockhardt
- Target Recruit Count
- 42
- Registration Number
- NCT00719108
- Locations
- 🇺🇸
Profil Institute for Clinical Research Inc., Chula Vista, California, United States
Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Novolin R, in Healthy Subjects.
Phase 1
Completed
- Conditions
- Diabetes Mellitus
- Interventions
- Biological: Wosulin RBiological: Novolin R
- First Posted Date
- 2008-01-16
- Last Posted Date
- 2012-12-27
- Lead Sponsor
- Wockhardt
- Target Recruit Count
- 25
- Registration Number
- NCT00596063
- Locations
- 🇺🇸
Profil Institute for Clinical Research Inc., Chula Vista, California, United States
🇺🇸Profil Institute for Clinical Research, Inc., Chula Vista, California, United States
© Copyright 2025. All Rights Reserved by MedPath